OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RIPK2 inhibitors for disease therapy: Current status and perspectives
Erkang Tian, Changhan Zhou, Shuqi Quan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115683-115683
Closed Access | Times Cited: 9
Erkang Tian, Changhan Zhou, Shuqi Quan, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115683-115683
Closed Access | Times Cited: 9
Showing 9 citing articles:
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 15
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 15
Current Trends in Clinical Trials of Prodrugs
Diogo Boreski, Volkmar H.R. Schmid, Priscila Longhin Bosquesi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 210-210
Open Access
Diogo Boreski, Volkmar H.R. Schmid, Priscila Longhin Bosquesi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 210-210
Open Access
Analysis of PANoptosis-related genes in septic cardiomyopathy by bioinformatics, machine learning and experimental validation
Yiheng Yang, Peng Yang, Xianbin Huang, et al.
Heliyon (2025), pp. e42882-e42882
Open Access
Yiheng Yang, Peng Yang, Xianbin Huang, et al.
Heliyon (2025), pp. e42882-e42882
Open Access
Tumor‐Adhesive Chitosan‐Derived Multi‐Immune Agonist Unleashes Strong and Durable Anti‐Cancer Immunity
Huilan He, Liang Liu, Yun Zheng, et al.
Advanced Science (2025)
Open Access
Huilan He, Liang Liu, Yun Zheng, et al.
Advanced Science (2025)
Open Access
RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination
Lu Chen, Hongda Liu, Tianyu Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Lu Chen, Hongda Liu, Tianyu Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, et al.
Cardiovascular Therapeutics (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 4
Wenyi Zhang, Mingduo Zhang, Jinfan Tian, et al.
Cardiovascular Therapeutics (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 4
Expression of Truncated Products at the 5′-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance
Ulises Mancini Villagra, Bianca Rodrigues da Cunha, Giovana Mussi Polachini, et al.
Genome Biology and Evolution (2024) Vol. 16, Iss. 7
Open Access
Ulises Mancini Villagra, Bianca Rodrigues da Cunha, Giovana Mussi Polachini, et al.
Genome Biology and Evolution (2024) Vol. 16, Iss. 7
Open Access
RIPK2 and lysosomal pathway: Unveiling a new mechanism for lung cancer metastasis
Wei Liu, Wei Xu, Huifang Hao, et al.
Translational Oncology (2024) Vol. 51, pp. 102182-102182
Closed Access
Wei Liu, Wei Xu, Huifang Hao, et al.
Translational Oncology (2024) Vol. 51, pp. 102182-102182
Closed Access
Analysis of immune cell activation in patients with diabetes foot ulcer from the perspective of single cell
Lung Vu, Fei Xu, Ting Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Lung Vu, Fei Xu, Ting Li, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
